PEDIATRIC AIDS CLINICAL TRIALS UNIT

儿科艾滋病临床试验单位

基本信息

  • 批准号:
    3548007
  • 负责人:
  • 金额:
    $ 75.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1992
  • 资助国家:
    美国
  • 起止时间:
    1992-04-01 至 1997-02-28
  • 项目状态:
    已结题

项目摘要

The goal of the University of Washington (UW) pediatric ACTU faculty is to perform exemplary HIV/AIDS treatment research in outpatients and inpatients as part of the national multicenter AIDS Clinical Trials Group (ACTG). The UW Pediatric ACTU's specific aims are to conduct Phase I, II and III studies in these areas: 1) primary pediatric infection; 2) opportunistic infections; and 3) perinatal trials. An additional aim is conduct of studies of opportunistic infections, especially genital infections with potential complications such as cervical cancer in women. We have an established investigative team including pediatrics, obstetrics, gynecology and internal medicine, experienced in performing antiviral and other clinical trials in pregnant women, infants and children. The UW is the referral center for a five-state region of the Pacific Northwest for HIV in children and pregnant women, and has followed 90 children and over 70% of the HIV seropositive pregnant women in this region. The states of Washington and Oregon have experienced a 40% increase in HIV seroprevalence in pregnant women from 1989 to 1990, and this increase has occurred mainly in ethnic minorities. Total minority numbers are 36% African American, 21 % Native American, 3% Hispanic and 2% Asian. We have established the Northwest Family Center (NWFC), a "one-stop-shopping" facility with a multicultural staff to provide clinical care, social support and access to ACTG clinical trials. As substance abuse was the mechanism of HIV infection in 80% of seropositive pregnant women, NWFC has co-located with a treatment program for chemically dependent pregnant women. We have the infrastructure to enroll and retain HIV infected pregnant women and their infants, as well as HIV infected children, on ACTG protocols in a culturally sensitive fashion. We will enroll at least 35 HIV infected pregnant women and their infants as well as 28 HIV infected children per year in clinical trials. This proposal seeks funding to achieve independent status as a Pediatric ACTU and establishment of the Oregon Subunit.
华盛顿大学(UW)儿科ACTU教师的目标是

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SANDRA K BURCHETT其他文献

SANDRA K BURCHETT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SANDRA K BURCHETT', 18)}}的其他基金

PACTG 1021:
PACTG 1021:
  • 批准号:
    7380710
  • 财政年份:
    2006
  • 资助金额:
    $ 75.36万
  • 项目类别:
PACTG 1015: HIV-SPECIFIC CD4 AND CD8 ACTIVITY BY RECYCLING HAART IN PEDS/ADOLES
PACTG 1015:在 PEDS/ADOLES 中回收 HAART 的 HIV 特异性 CD4 和 CD8 活性
  • 批准号:
    7380713
  • 财政年份:
    2006
  • 资助金额:
    $ 75.36万
  • 项目类别:
PACTG 1045: PREVALENCE OF MORPHOLOGIC & METABOLIC ADNORMALITIES IN VERTICALLY
PACTG 1045:形态学的流行
  • 批准号:
    7204726
  • 财政年份:
    2005
  • 资助金额:
    $ 75.36万
  • 项目类别:
PACTG 1015: HIV-SPECIFIC CD4 AND CD8 ACTIVITY BY RECYCLING HAART IN PEDS/ADOLES
PACTG 1015:在 PEDS/ADOLES 中回收 HAART 的 HIV 特异性 CD4 和 CD8 活性
  • 批准号:
    7204681
  • 财政年份:
    2005
  • 资助金额:
    $ 75.36万
  • 项目类别:
ACTG P1010: Effect of antiretroviral therapy on body composition in HIV-infecte
ACTG P1010:抗逆转录病毒治疗对 HIV 感染者身体成分的影响
  • 批准号:
    6975117
  • 财政年份:
    2004
  • 资助金额:
    $ 75.36万
  • 项目类别:
PACTG 1021:
PACTG 1021:
  • 批准号:
    6975138
  • 财政年份:
    2004
  • 资助金额:
    $ 75.36万
  • 项目类别:
PACTG 1030
PACTG 1030
  • 批准号:
    6975146
  • 财政年份:
    2004
  • 资助金额:
    $ 75.36万
  • 项目类别:
PACTG 1015: HIV-specific CD4 and CD8 activity by recycling HAART in peds/adoles.
PACTG 1015:通过在儿童/青少年中回收 HAART 来发挥 HIV 特异性 CD4 和 CD8 活性。
  • 批准号:
    6975144
  • 财政年份:
    2004
  • 资助金额:
    $ 75.36万
  • 项目类别:
PEDIATRIC AIDS CLINICAL TRIALS UNIT
儿科艾滋病临床试验单位
  • 批准号:
    3548008
  • 财政年份:
    1992
  • 资助金额:
    $ 75.36万
  • 项目类别:

相似海外基金

Basic and applied study on AIDS-therapy using hybrid liposomes
混合脂质体治疗艾滋病的基础与应用研究
  • 批准号:
    24656509
  • 财政年份:
    2012
  • 资助金额:
    $ 75.36万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
SIV MODEL FOR MULTI DRUG RESISTANCE TO AIDS THERAPY
艾滋病治疗多重耐药性的 SIV 模型
  • 批准号:
    6940442
  • 财政年份:
    2003
  • 资助金额:
    $ 75.36万
  • 项目类别:
RT-SHIV MODEL FOR RESISTANCE TO AIDS THERAPY
艾滋病治疗抵抗力的 RT-SHIV 模型
  • 批准号:
    6940441
  • 财政年份:
    2003
  • 资助金额:
    $ 75.36万
  • 项目类别:
Mitochondrial Toxicity of Antiviral Nucleosides in AIDS Therapy
艾滋病治疗中抗病毒核苷的线粒体毒性
  • 批准号:
    7421121
  • 财政年份:
    2002
  • 资助金额:
    $ 75.36万
  • 项目类别:
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY
干细胞的靶向操作用于艾滋病治疗
  • 批准号:
    6312501
  • 财政年份:
    2001
  • 资助金额:
    $ 75.36万
  • 项目类别:
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY
干细胞的靶向操作用于艾滋病治疗
  • 批准号:
    6499098
  • 财政年份:
    2001
  • 资助金额:
    $ 75.36万
  • 项目类别:
Targeted Manipulation of Stem Cells for AIDS Therapy
干细胞的靶向操作用于艾滋病治疗
  • 批准号:
    7479315
  • 财政年份:
    2001
  • 资助金额:
    $ 75.36万
  • 项目类别:
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY
干细胞的靶向操作用于艾滋病治疗
  • 批准号:
    6708893
  • 财政年份:
    2001
  • 资助金额:
    $ 75.36万
  • 项目类别:
Targeted Manipulation of Stem Cells for AIDS Therapy
干细胞的靶向操作用于艾滋病治疗
  • 批准号:
    7666728
  • 财政年份:
    2001
  • 资助金额:
    $ 75.36万
  • 项目类别:
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY
干细胞的靶向操作用于艾滋病治疗
  • 批准号:
    6849724
  • 财政年份:
    2001
  • 资助金额:
    $ 75.36万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了